Literature DB >> 26423404

The clinical significance of systemic inflammation score in esophageal squamous cell carcinoma.

Lihui Han1, Qingxu Song1, Yibin Jia1, Xuan Chen1, Cong Wang1, Pengxiang Chen1, Rui Min1, Yufeng Cheng2.   

Abstract

The objective of this study was to investigate the clinical significance of systemic inflammation score (SIS) and prognostic nutritional index (PNI) in esophageal squamous cell carcinoma (ESCC) patients who underwent esophagectomy. Records from 206 patients with histologically diagnosed ESCC who underwent esophagectomy at Qilu Hospital of Shandong University from January 2007 to December 2008 were retrospectively reviewed. The median disease-free survival (DFS) of this cohort was 32.3 months and 5-year DFS was 34.5 %. The median overall survival (OS) was 39.5 months and 5-year OS was 40.8 %. We found that high SIS was significantly associated with increased tumor length (p = 0.021), increased depth of invasion (p = 0.001), lymph node metastasis (p = 0.038), and advanced pathological stage (p = 0.004). Kaplan-Meier survival analysis revealed that both high SIS and low PNI were significantly associated with inferior DFS (for the SIS, p = 0.005; for the PNI, p = 0.003) and OS (for the SIS, p = 0.007; for the PNI, p = 0.002). In multivariate analysis, SIS was an independent prognostic indicator for both DFS and OS. However, PNI was not an independent prognosticator in multivariate analysis. SIS was a novel and promising inflammation-based prognostic score than PNI in ESCC patients who underwent esophagectomy.

Entities:  

Keywords:  Esophageal cancer; Prognosis; Prognostic nutritional index; Squamous cell carcinoma; Systemic inflammation score

Mesh:

Substances:

Year:  2015        PMID: 26423404     DOI: 10.1007/s13277-015-4152-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  31 in total

1.  Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma.

Authors:  T Nozoe; Y Kimura; M Ishida; H Saeki; D Korenaga; K Sugimachi
Journal:  Eur J Surg Oncol       Date:  2002-06       Impact factor: 4.424

2.  Which factors are associated with actual 5-year survival of oesophageal squamous cell carcinoma?

Authors:  Jingeng Liu; Xuan Xie; Chao Zhou; Sujiang Peng; Dongping Rao; Jianhua Fu
Journal:  Eur J Cardiothorac Surg       Date:  2011-12-29       Impact factor: 4.191

3.  Prognostic nutritional index in gastrointestinal surgery.

Authors:  G P Buzby; J L Mullen; D C Matthews; C L Hobbs; E F Rosato
Journal:  Am J Surg       Date:  1980-01       Impact factor: 2.565

4.  Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.

Authors:  Tormund S Njølstad; Hilde Engerud; Henrica M J Werner; Helga B Salvesen; Jone Trovik
Journal:  Gynecol Oncol       Date:  2013-09-01       Impact factor: 5.482

5.  The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma.

Authors:  Tadahiro Nozoe; Mayuko Kohno; Tomohiro Iguchi; Emiko Mori; Takashi Maeda; Akito Matsukuma; Takahiro Ezaki
Journal:  Surg Today       Date:  2011-12-03       Impact factor: 2.549

Review 6.  Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis.

Authors:  Arnoud J Templeton; Olga Ace; Mairéad G McNamara; Mustafa Al-Mubarak; Francisco E Vera-Badillo; Thomas Hermanns; Boštjan Seruga; Alberto Ocaña; Ian F Tannock; Eitan Amir
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-03       Impact factor: 4.254

7.  Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer?

Authors:  Andrew B C Crumley; Robert C Stuart; Margaret McKernan; Donald C McMillan
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

8.  Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

Authors:  Bernhard Mlecnik; Marie Tosolini; Amos Kirilovsky; Anne Berger; Gabriela Bindea; Tchao Meatchi; Patrick Bruneval; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès; Jérôme Galon
Journal:  J Clin Oncol       Date:  2011-01-18       Impact factor: 44.544

9.  The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage.

Authors:  Kazuhiro Migita; Tomoyoshi Takayama; Keigo Saeki; Sohei Matsumoto; Kohei Wakatsuki; Koji Enomoto; Tetsuya Tanaka; Masahiro Ito; Norio Kurumatani; Yoshiyuki Nakajima
Journal:  Ann Surg Oncol       Date:  2013-03-06       Impact factor: 5.344

10.  Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma.

Authors:  Y Chang; H An; L Xu; Y Zhu; Y Yang; Z Lin; J Xu
Journal:  Br J Cancer       Date:  2015-07-02       Impact factor: 7.640

View more
  14 in total

1.  Cancer Recurrence After Esophagectomy: Impact of Postoperative Infection in Propensity-Matched Cohorts.

Authors:  Vernissia Tam; James D Luketich; Daniel G Winger; Inderpal S Sarkaria; Ryan M Levy; Neil A Christie; Omar Awais; Manisha R Shende; Katie S Nason
Journal:  Ann Thorac Surg       Date:  2016-06-25       Impact factor: 4.330

2.  Platelet-to-Lymphocyte Ratio Multiplied by the Cytokeratin-19 Fragment Level as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma.

Authors:  Yuji Shishido; Tomoyuki Matsunaga; Shohei Sawata; Masahiro Makinoya; Wataru Miyauchi; Kozo Miyatani; Chihiro Uejima; Masaki Morimoto; Yuki Murakami; Takehiko Hanaki; Kyoichi Kihara; Manabu Yamamoto; Naruo Tokuyasu; Shuichi Takano; Teruhisa Sakamoto; Hiroaki Saito; Toshimichi Hasegawa; Yoshiyuki Fujiwara
Journal:  Yonago Acta Med       Date:  2021-08-24       Impact factor: 1.641

3.  Long-term impact of prognostic nutritional index in cervical esophageal squamous cell carcinoma patients undergoing definitive radiotherapy.

Authors:  Yaqing Dai; Xiaobin Fu; Tingting Li; Qiwei Yao; Liyu Su; Huiyan Su; Jiancheng Li
Journal:  Ann Transl Med       Date:  2019-04

4.  Perioperative Predictive Markers for Recurrence of Esophageal Cancer after Esophagectomy.

Authors:  Yoshinori Fujiwara; Masaharu Higashida; Hisako Kubota; Yuko Okamoto; Shumei Mineta; Shunji Endo; Tomio Ueno
Journal:  Gastrointest Tumors       Date:  2021-03-17

5.  Prognosis impact of clinical characteristics in patients with inoperable esophageal squamous cell carcinoma.

Authors:  Ying Yang; Jun Jia; Zhiwei Sun; Feng Du; Jing Yu; Chuanling Liu; Yanjie Xiao; Xiaodong Zhang
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

6.  Pretreatment NRS-2002 scores combined with hematologic inflammation markers are independent prognostic factors in patients with resectable thoracic esophageal squamous cell carcinoma.

Authors:  Xin-Wei Guo; Yang-Chen Liu; Fei Gao; Sheng-Jun Ji; Ju-Ying Zhou; Lei Ji; Shao-Bing Zhou
Journal:  Cancer Manag Res       Date:  2018-08-02       Impact factor: 3.989

7.  The role of pretreatment prognostic nutritional index in esophageal cancer: A meta-analysis.

Authors:  Yibo Xue; Xiang Zhou; Lei Xue; Ruhua Zhou; Jinhua Luo
Journal:  J Cell Physiol       Date:  2019-04-04       Impact factor: 6.384

8.  The prognostic value of pre-treatment prognostic nutritional index in esophageal squamous cell carcinoma: A meta-analysis.

Authors:  Pengfei Li; Xin Wang; Yutian Lai; Kun Zhou; Yuxin Tang; Guowei Che
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

9.  Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients.

Authors:  Daichi Nomoto; Yoshifumi Baba; Takahiko Akiyama; Kazuo Okadome; Masaaki Iwatsuki; Shiro Iwagami; Yuji Miyamoto; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  Ann Gastroenterol Surg       Date:  2021-06-15

10.  Feasibility of esophagectomy for esophageal cancer in elderly patients: a case-control study.

Authors:  Nobuhiro Tsuchiya; Chikara Kunisaki; Sho Sato; Yusaku Tanaka; Kei Sato; Jun Watanabe; Kazuhisa Takeda; Takashi Kosaka; Hirotoshi Akiyama; Itaru Endo
Journal:  Langenbecks Arch Surg       Date:  2021-07-14       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.